IDEX Biometrics ASA (OSL:IDEX) Research & Development: kr11.14 Mil (TTM As of Mar. 2026)


OSL:IDEX IDEX Biometrics ASA OSL:IDEX
20 GF Score
Price kr8.20
GF Value kr0.53
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is IDEX Biometrics ASA Research & Development?

IDEX Biometrics ASA OSL:IDEX +3.02% 20 Research & Development is kr11.14 Mil as of Mar. 2026. GuruFocus rates OSL:IDEX with a GF Score™ of 20/100 and a GF Value™ of kr0.53 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. IDEX Biometrics ASA's Research & Development for the three months ended in Mar. 2026 was kr2.94 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was kr11.14 Mil.

IDEX Biometrics ASA  (OSL:IDEX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

IDEX Biometrics ASA Research & Development Related Terms

IDEX Biometrics ASA Research & Development Historical Data

* Premium members only.

The historical data trend for IDEX Biometrics ASA's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDEX Biometrics ASA Research & Development Chart

IDEX Biometrics ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.64 31.85 24.34 27.86 13.70

IDEX Biometrics ASA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.67 5.36 3.51 -0.66 2.94
OSL:IDEX
20GF Score
IDEX Biometrics ASA OSL:IDEX
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IDEX Biometrics ASA Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr11.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of kr11.14 Mil mean?
IDEX Biometrics ASA (OSL:IDEX) has a Research & Development of kr11.14 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on IDEX Biometrics ASA and its competitors.
Is IDEX Biometrics ASA's Research & Development too high?
IDEX Biometrics ASA's current Research & Development is kr11.14 Mil. Overall, IDEX Biometrics ASA has a GF Score™ of 20/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IDEX Biometrics ASA's Research & Development compare to UBER and SHOP?
IDEX Biometrics ASA's Research & Development of kr11.14 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Software company?
A good Research & Development depends on the Software industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on IDEX Biometrics ASA and its competitors. IDEX Biometrics ASA's current Research & Development is kr11.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDEX Biometrics ASA stock overvalued right now?
Based on GuruFocus' analysis, IDEX Biometrics ASA (OSL:IDEX) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.53, compared to a current price of kr8.20 — trading 1447.2% above its estimated fair value. The current Research & Development is kr11.14 Mil. IDEX Biometrics ASA's overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For IDEX Biometrics ASA (OSL:IDEX), the current Research & Development is kr11.14 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IDEX Biometrics ASA (OSL:IDEX) Overvalued in 2026?

Based on GuruFocus' analysis, IDEX Biometrics ASA stock appears to be overvalued. The current stock price of kr8.20 is trading 1447.2% above its estimated GF Value™ of kr0.53. GuruFocus considers IDEX Biometrics ASA to be Significantly Overvalued.

Key valuation signals for OSL:IDEX:

  • Research & Development: kr11.14 Mil
  • GF Value™: kr0.53 vs. price of kr8.20 (1447.2% above fair value)
  • GF Score™: 20/100 with 5 warning signs

No single metric tells the full story. See the OSL:IDEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IDEX Biometrics ASA Business Description

Other Exchanges IDXAF:USA0MTP:UKI8X:Germany
Address Henrik Ibsens gate 90, Oslo, NOR, 0255
IDEX Biometrics ASA develops and manufactures fingerprint biometric cards for access control, digital identity, and payment. Its products use fingerprint biometrics for user authentication and are designed for physical and digital access applications. The company serves banks, enterprises, and public sector organizations through direct sales and channel partners.
20GF Score

Get the complete analysis for OSL:IDEX

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr8.20
Price
kr0.53
GF Value